Sanofi-Aventis CEO Chris Viehbacher has support from his board of directors to offer as much as $70 a share for Genzyme Corp., or about $18.7 billion, three people with knowledge of the situation told Bloomberg News.
Sanofi-Aventis CEO Chris Viehbacher has support from his board of directors to offer as much as $70 a share for Genzyme Corp., or about $18.7 billion, three people with knowledge of the situation told Bloomberg News.
Copyright © 2021 Wall Street Pit | Contact Us | Advertise | Terms of Use | Privacy Policy
Leave a Reply